Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Tjoapack invests in blistering capabilities

Global contract packaging organisation (CPO), Tjoapack has invested in its blistering capacity, adding a new line that will be equipped with late-stage customisation printing capabilities.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Global contract packaging organisation (CPO), Tjoapack has invested in its blistering capacity, adding a new line that will be equipped with late-stage customisation printing capabilities.

Expected to be operational by the end of Q3 2018, the new line, at the company’s facility in Etten-Leur, Netherlands, will take its total number of blistering lines to eight.

“At Tjoapack we’re committed to ensuring our customers continue to receive the efficient and flexible service that they’re used to, so we’re always looking for ways to further improve our operations to allow us to better cater for their projects.

“We have a strategic growth plan in place and increasing our blistering capacity will allow us to cater for increasing demand from both current and new customers.”

The investment will also expand Tjoapack’s current postponement printing offering, enabling the CPO to offer drop-on-demand digital printing for blisters.

“Late-stage customisation, or postponement printing, is something that is presenting some interesting benefits for the pharmaceutical supply chain. The process of only making packaging market-specific once there is a demand could be hugely beneficial in terms of reducing waste from repackaging, overall costs and time to market.

“We’ve started to explore this type of packaging with some of our customers already and as more complex molecules continue to enter the drug pipeline, demand for last-minute packaging is likely to increase. This investment will allow us to futureproof our lines for projected demands.”

This latest investment will be supported by continued growth of the CPO’s commercial, operational and quality teams.

Founded in 1989, Tjoapack is an independent contract packager of medicines servicing clients across five continents and 42 countries.

The CPO specialises in primary packaging for solid dosage forms, secondary packaging and unit dose packaging and now has a total of 19 packaging lines for blisters, wallets and bottles. Using these lines, it packages around 26 million packs of pharmaceutical products per year, which equates to around 1.4 billion tablets.

For more information, click here

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report